Form 8-K · Current report

Labcorp 8-K, filed Sep 10, 2026

Filed
CIK
0000920148
Accession no.
0000920148-26-000201
AI-generated summary

Summary

Labcorp hosted its 2026 Investor Day, reaffirmed full-year 2026 guidance, and provided a long-term outlook through 2029 with compound annual revenue growth of 5% to 8% and compound annual adjusted EPS growth of 8.5% to 11.5%. CEO Adam Schechter and CFO Julia Wang presented the company's strategic priorities and value creation framework.

Key points

  • Labcorp reaffirmed its full-year 2026 guidance, including enterprise revenue of $14.710 billion to $14.827 billion and adjusted EPS of $18.10 to $18.55.
  • Labcorp provided a long-term outlook through 2029 with compound annual revenue growth of 5% to 8% and compound annual adjusted EPS growth of 8.5% to 11.5%.
  • Labcorp outlined four strategic priorities: leading in specialty testing, being a partner for health systems and pharmaceutical companies, driving personalized health solutions, and using advanced technology including artificial intelligence and robotics.
  • CEO Adam Schechter said the growth strategy supports above-market performance; CFO Julia Wang cited a disciplined value creation framework converting growth into earnings, cash flow, and shareholder returns.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

Item 7.01. Regulation FD Disclosure. Labcorp Holdings Inc. (the “Company”) (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today hosted its 2026 Investor Day (“Investor Day”), where the company provided an in-depth review of its growth strategy, innovation roadmap, and long-term financial outlook. In connection with Investor Day, the Company issued a press release that, among other things, discussed its business strategy, reaffirmed its full-year 2026 guidance, and provided its long-term financial outlook through 2029. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Labcorp in Readster

Add Labcorp to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.